The Oncology Institute, Inc. (TOIIW) Free cash flow 2020–2025
The Oncology Institute, Inc. (TOIIW) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$27.8MFY2025 · since FY2020: -$686,000 → -$27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$27.8M | +8.4% |
| FY2024 | -$30.3M | +25.8% |
| FY2023 | -$40.9M | +39.2% |
| FY2022 | -$67.3M | -89.4% |
| FY2021 | -$35.5M | -5078.9% |
| FY2020 | -$686,000 | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice